Advancements in COPD Management: Singapore’s HSA Approves Revefenacin (Yupelri®)By KayeNovember 16, 20210 Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory lung disease characterised by irreversible airflow limitation and associated with significant…
